Overview
Current NAV
318.4351
As on 30-Dec-2025
Fund Size
1,126.131 Cr
Managed by V Srivatsa, Ritesh Rathod
Expense Ratio
1.28%
Latest reported
Exit Load Rules
4
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 01-Jan-2013. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.64 | — | — | — |
| 1W | -1.70 | — | — | — |
| 1M | -2.90 | — | — | — |
| 3M | -0.51 | — | 1.47 | — |
| 6M | 0.19 | — | 0.20 | — |
| 1Y | -2.09 | — | -2.14 | — |
| 3Y | 25.04 | 25.04 | 22.11 | — |
| 5Y | 15.96 | 15.96 | 14.61 | — |
| 10Y | 12.61 | 12.61 | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
9.76
Ajanta Pharma Ltd.
EQ
Healthcare
6.48
Lupin Ltd.
EQ
Healthcare
5.91
Glenmark Pharmaceuticals Ltd.
EQ
Healthcare
4.06
Dr. Reddy's Laboratories Ltd.
EQ
Healthcare
3.74
Gland Pharma Ltd.
EQ
Healthcare
3.46
Apollo Hospitals Enterprise Ltd.
EQ
Healthcare
3.45
Alkem Laboratories Ltd.
EQ
Healthcare
3.43
Procter & Gamble Health Ltd.
EQ
Healthcare
3.41
Cipla Ltd.
EQ
Healthcare
3.40
Jupiter Life Line Hospitals Ltd.
EQ
Healthcare
2.98
Divi's Laboratories Ltd.
EQ
Healthcare
2.88
Analysis Highlights
PROS
Lower expense ratio: 1.28%
PROS
Consistently higher annualised returns than category average for the past 1Y, 3Y, 5Y and 10Y
Exit Load
- Exit load of 1% if redeemed within 30 days.2021-04-01
- Exit load of 1% if redeemed less than 1 year2015-04-06
- Exit load of 1% if redeemed within 548 days2014-10-01
- Exit load of 1% if redeemed less than 1 year2013-01-01